These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7546629)

  • 1. Nitric oxide and airway disease.
    Barnes PJ
    Ann Med; 1995 Jun; 27(3):389-93. PubMed ID: 7546629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airborne nitric oxide: inflammatory marker and aerocrine messenger in man.
    Lundberg JO
    Acta Physiol Scand Suppl; 1996; 633():1-27. PubMed ID: 8876755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid.
    Saleh D; Ernst P; Lim S; Barnes PJ; Giaid A
    FASEB J; 1998 Aug; 12(11):929-37. PubMed ID: 9707165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide.
    Watkins DN; Garlepp MJ; Thompson PJ
    Br J Pharmacol; 1997 Aug; 121(7):1482-8. PubMed ID: 9257931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway nitric oxide output is reduced in bronchiectasis.
    Foley SC; Hopkins NO; Fitzgerald MX; Donnelly SC; McLoughlin P
    Respir Med; 2007 Jul; 101(7):1549-55. PubMed ID: 17234397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis.
    Batra J; Chatterjee R; Ghosh B
    Indian J Biochem Biophys; 2007 Oct; 44(5):303-9. PubMed ID: 18341205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli.
    Sareila O; Hämäläinen M; Nissinen E; Kankaanranta H; Moilanen E
    J Pharmacol Exp Ther; 2008 Feb; 324(2):858-66. PubMed ID: 18039960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO or no NO in asthma?
    Barnes PJ
    Thorax; 1996 Feb; 51(2):218-20. PubMed ID: 8711662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of inducible nitric oxide synthase in asthmatic rat lung].
    Huang T; Lin Y; Chen Y; Zhu Y; Luo W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):186-9. PubMed ID: 12903525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat.
    Kallio EA; Koskinen PK; Aavik E; Vaali K; Lemstöm KB
    J Clin Invest; 1997 Dec; 100(12):2984-94. PubMed ID: 9399944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of nitric oxide and nitric oxide synthase in the pathogenesis of asthma].
    Jiang D; Li H; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):204-7. PubMed ID: 11326963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB.
    Lin YL; Lin JK
    Mol Pharmacol; 1997 Sep; 52(3):465-72. PubMed ID: 9281609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitric oxide (NO) in the pathophysiology of asthma and interstitial lung diseases].
    Kasperska-Zajac A; Rogala B
    Postepy Hig Med Dosw; 2001; 55(4):525-40. PubMed ID: 11766229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and bronchial hyperresponsiveness.
    Nijkamp FP; Folkerts G
    Arch Int Pharmacodyn Ther; 1995; 329(1):81-96. PubMed ID: 7639622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
    Hecker M; Preiss C; Schini-Kerth VB
    Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by lipid-associated membrane proteins isolated from Mycoplasma penetrans.
    Zeng YH; Wu YM; Zhang WB; Yu MJ; Zhu CM; Tan LZ
    Chin Med J (Engl); 2004 Jul; 117(7):997-1001. PubMed ID: 15265371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia.
    Al-Ali MK; Howarth PH
    Saudi Med J; 2001 Mar; 22(3):249-53. PubMed ID: 11307112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I.
    Bergeron C; Boulet LP; Page N; Laviolette M; Zimmermann N; Rothenberg ME; Hamid Q
    J Allergy Clin Immunol; 2007 Feb; 119(2):391-7. PubMed ID: 17291856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.